On September 5th, 2024, Katherine Scott and Lana Duan from MORSE Consulting presented “Accelerating Access: Leveraging Target Zero to Expedite Time to Access for New Therapies” at the CDA-AMC Symposium. They explored how pre-NOC submissions impact market access timelines, using CDA-validated data and insights from our internal database.
Download our presentation to learn more about these findings and strategies for accelerating access to new therapies.
Panelists
We’d like to thank all our esteemed panelists for their contributions:
- Beth Kidd (Health Coalition of Alberta)
- Imran Ali (Bristol-Myers Squibb Canada)
- Sudha Kutty (Canada’s Drug Agency)
- Angie Wong (Ontario Ministry of Health)
- Katherine Scott (MORSE Consulting)
- Lana Duan (MORSE Consulting)
Download Presentation
We're committed to your privacy. MORSE may use the information you provide to us to contact you about our relevant content and services. Your name, address and all other personal information will not be sold or given to any other organization or list distributor. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.
